Vanguard Personalized Indexing Management, LLC Nuvation Bio Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.09 Billion
- Q3 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 16,083 shares of NUVB stock, worth $43,263. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,083
Previous 16,070
0.08%
Holding current value
$43,263
Previous $46,000
21.74%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NUVB
# of Institutions
159Shares Held
157MCall Options Held
3.2KPut Options Held
98.7K-
Decheng Capital LLC Menlo Park, CA26MShares$69.8 Million14.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA19.2MShares$51.7 Million1.92% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$43.7 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$35.2 Million44.61% of portfolio
-
Octagon Capital Advisors LP New York, NY12.2MShares$32.7 Million6.76% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $584M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...